Geode Capital Management’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.86M | Buy |
|
|||||
|
2025
Q1 | $7.95M | Buy |
|
|||||
|
2024
Q4 | $8.12M | Buy |
|
|||||
|
2024
Q3 | $6.92M | Buy |
|
|||||
|
2024
Q2 | $7.27M | Sell |
|
|||||
|
2024
Q1 | $8.68M | Sell |
|
|||||
|
2023
Q4 | $11.2M | Sell |
|
|||||
|
2023
Q3 | $9.16M | Sell |
|
|||||
|
2023
Q2 | $12.1M | Sell |
|
|||||
|
2023
Q1 | $12.9M | Buy |
|
|||||
|
2022
Q4 | $12.8M | Buy |
|
|||||
|
2022
Q3 | $10.9M | Buy |
|
|||||
|
2022
Q2 | $9.31M | Buy |
|
|||||
|
2022
Q1 | $9.66M | Sell |
|
|||||
|
2021
Q4 | $11.5M | Buy |
|
|||||
|
2021
Q3 | $5.15M | Sell |
|
|||||
|
2021
Q2 | $13.5M | Buy |
|
|||||
|
2021
Q1 | $17.1M | Buy |
|
|||||
|
2020
Q4 | $13.4M | Buy |
|
|||||
|
2020
Q3 | $10.9M | Buy |
|
|||||
|
2020
Q2 | $15.1M | Buy |
|
|||||
|
2020
Q1 | $16.6M | Buy |
|
|||||
|
2019
Q4 | $15.8M | Sell |
|
|||||
|
2019
Q3 | $11.9M | Buy |
|
|||||
|
2019
Q2 | $9.56M | Buy |
|
|||||
|
2019
Q1 | $12.3M | Buy |
|
|||||
|
2018
Q4 | $12.7M | Buy |
|
|||||
|
2018
Q3 | $14.7M | Buy |
|
|||||
|
2018
Q2 | $9.86M | Buy |
|
|||||
|
2018
Q1 | $9.53M | Buy |
|
|||||
|
2017
Q4 | $10.4M | Buy |
|
|||||
|
2017
Q3 | $12.3M | Buy |
|
|||||
|
2017
Q2 | $14.1M | Buy |
|
|||||
|
2017
Q1 | $12.2M | Buy |
|
|||||
|
2016
Q4 | $9.95M | Buy |
|
|||||
|
2016
Q3 | $9.64M | Buy |
|
|||||
|
2016
Q2 | $5.57M | Buy |
|
|||||
|
2016
Q1 | $3.63K | Buy |
|
|||||
|
2015
Q4 | $2.92M | Buy |
|
|||||
|
2015
Q3 | $1.86M | Buy |
|
|||||
|
2015
Q2 | $2.11M | Buy |
|
|||||
|
2015
Q1 | $2.38M | Buy |
|
|||||
|
2014
Q4 | $2.02M | Buy |
|
|||||
|
2014
Q3 | $3.04M | Buy |
|
|||||
|
2014
Q2 | $4.14M | Buy |
|